Xiaomei Gu and her team members: Javier Mendivil, Louis Lozouet, Marcus Werlang, Silke Musa and Stefano Piantoni researched and presented findings on the topic:
Healthcare 2.0: Towards a more efficient business model
How time flies! Now we come to a slot that is one of the most astonishing parts of our MBA program – Navigating The Future 2017. As a conference prepared and organized by the MBA participants, Navigating The Future provides us, potential future leaders, with an opportunity to dig deep and address new trends, opportunities and challenges across industries all over the world.
Studying in Switzerland, the location for headquarters of many pharma and health science organizations, how could we miss the topic on healthcare? As one of the 15 teams, our team had the opportunity and pleasure to address “Healthcare 2.0: towards a more efficient business model” on the afternoon of 22nd June.
No doubt that globally the operation of the current healthcare model is a model that leads to mounting cost pressure and low efficiency across the healthcare circle ranging from R&D, service providers, medicine providers to payers.
Healthcare 2.0 recommends and highlights patient outcome, cost containment, integration of all stakeholders across the value chain, and a value based payment system, aiming at improving the outcome of care delivery and lowering the cost by providing the right dosage of the right drug to the right patients, at the right time, at the right place, at the right cost. Successful cases in part of the value chain have already had very promising outcomes across the globe.
Businesses should now pay more attention to the increasing role of diagnosis, precision medicine, empowerment of patients, and application of data driven by new technologies such as wearable devices and block chain. To maintain competitive advantages in the evolving new system, should businesses adjust their R&D strategy, should they invest more on big data? Should they build partnerships with disruptive start-ups in these areas or should they consider more M&A?
Different opinions were brought up during our post-presentation Q&A session, yet, one thing is certain, healthcare is evolving to a new model, and companies should reconsider their strategy and prepare for both the opportunities and challenges to come in the near future.
How true that “great minds think alike”, yet the most fascinating thing for me when preparing our topic with my team is what diversity can lead us to. Being in a group with different backgrounds, cultures and mind-sets, I see more inspiration than conflicts; more added value than arguments; more collaboration than arrogance. Like the new potential healthcare 2.0, we ourselves are on our way: learning, changing, and being ready to impact the future business in a more international context.
Xiaomei
MBA 2017
